Estera Phase I
by Pharmanex · softgel capsule · 60 softgels
- Off the market since October 2023 (NIH)
- DSLD label 215061
- Serving 2 softgels
- 30 servings
Estera Phase I by Pharmanex lists 8 ingredients, 8 with an amount per serving of 2 softgels, such as 50 mg of vitamin B6, 500 mg of evening primrose oil, 250 mg of borage seed oil and 250 mg of chasteberry fruit (vitex agnus/castus L.) extract. Its current label entered the NIH Dietary Supplement Label Database on March 24, 2020.
What is in Estera Phase I?
Each row as the label prints it, per serving of 2 softgels. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).
| Ingredient | Amount | % DV | Among products listing it |
|---|---|---|---|
| Vitamin B6as Pyridoxine HydrochlorideVitamin B6 (Form: as Pyridoxine Hydrochloride) | 50 mg | 2,941% | Higher than 87% of 15,277 products listing vitamin B6 (median 6 mg). |
| Evening Primrose Oil | 500 mg | 50% of 300 products listing evening primrose oil give more (median 500 mg). | |
| Borage seed Oil | 250 mg | 69% of 254 products listing borage oil give more (median 515 mg). | |
| Chasteberry fruit (Vitex agnus/castus L.) extract | 250 mg | Higher than 75% of 386 products listing chastetree (median 100 mg). | |
| DiindolylmethaneDiindolylmethane Note: an indole | 100 mg | 47% of 425 products listing diindolylmethane give more (median 100 mg). | |
| Pomegranate fruit (Punica granatum) extract | 40 mg | 61% of 860 products listing pomegranate give more (median 70.5 mg). | |
| Lignansas FlaxseedLignans (Form: from Flaxseed) | 15 mg | 85% of 54 products listing lignan give more (median 35 mg). | |
| Genisteinas Soy Isoflavone ext.Genistein (Form: from 64% Soy Isoflavone Ext.) | 10 mg | 66% of 62 products listing genistein give more (median 24.2 mg). |
Source: NIH ODS Dietary Supplement Label Database, label 215061 (entered March 24, 2020), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.
Is that a lot?
Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.
The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.
The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.
Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.
Which products have the closest formulas?
The products whose ingredient lists overlap most with Estera Phase I's, rare ingredients counting for more.
- Estera Phase IIIPharmanex · off the market 4 shared, 52% alike
- Estera Phase IIPharmanex · off the market 4 shared, 47% alike
- Evening Primrose Oil 1000 mgEsmond Natural 3 shared, 39% alike
Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.
What does the label say about taking it?
Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.
- Directions
- Directions for use: As a dietary supplement, take two (2) softgels daily, preferably one with your morning and evening meals.
- Warnings
- Warning: Keep out of reach of children.
- If you are pregnant or lactating, or taking a prescription medication, consult a physician before using this product.
- Discontinue 2 weeks prior to and after surgery. Discontinue use and consult a physician if any adverse reactions occur. Do not use if safety seal is broken or missing.
- Contains soy.
- Storage
- Store in a cool, dry place.
Source: label statements in DSLD label 215061.
What else is on the label?
Other ingredients: Gelatin, Glycerine, Soy Oil, Beeswax, Caramel.
Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): 6S Quality.
How many labels does Estera Phase I have?
3 labels are on file under this name since November 25, 2013: other sizes, label designs and reformulations. The current one leads this page.
- Label 215061 (current) Entered March 24, 2020 · off the market October 16, 2023 · 60 softgels
- Label 78831 Entered October 21, 2017 · off the market August 20, 2019 · 60 softgels
- Label 27774 Entered November 25, 2013 · off the market August 24, 2017 · 60 softgels
Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).
Who makes it?
The label names NSE Products, Inc. (distributor), Provo, UT. All Pharmanex products.